Evidence map›Paper›PMID 22520521›Full record

Trial reportAmerican heart journal2012

Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.

Harvey D White, Harmony R Reynolds, Antonio C Carvalho, Camille A Pearte, Li Liu, C Edwin Martin, Genell L Knatterud, Vladimír Džavík, Mariusz Kruk, Philippe Gabriel Steg and 4 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in American heart journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00004562 (Occluded Artery Trial), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00004562 phase3completednot on this map

Occluded Artery Trial (OAT) - Randomized Comparative Effectiveness Trial of PCI and Medical Therapy Only Post MI

TypeinterventionalSponsorNYU Langone HealthRan1999 to 2011Enrolled2,201ConditionsCardiovascular Diseases, Heart Diseases, Myocardial Infarction, Heart Failure, CongestiveArmsBeta adrenergic blockers, Platelet inhibitors, PTCA and stents, ACE Inhibitors
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Article
  17. Fibroblast KATP currents modulate myocyte electrophysiology in infarcted hearts.American journal of physiology. Heart and circulatory physiology · 2013
    Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 6 countries.

Harvey D WhiteGreen Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand. HarveyW@adhb.govt.nz
Harmony R Reynolds
Antonio C Carvalho
Camille A Pearte
Li Liu
C Edwin Martin
Genell L Knatterud
Vladimír Džavík
Mariusz Kruk
Philippe Gabriel Steg
Warren J Cantor
Venu Menon
Gervasio A Lamas
Judith S Hochman
New York University · USAssistance Publique – Hôpitaux de Paris · FRAuckland City Hospital · NZCleveland Clinic · USClinical Trials and Surveys Corporation · USHospital São Paulo · BRInstitute of Cardiology · PLMaryland Medical Research Institute · USMount Sinai Medical Center · USSouthlake Regional Health Center · CAUniversity Health Network · CAYork General Hospital · US

Funding

Occluded Artery Trial: Long Term Follow-UpU01HL062509 · NHLBI · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI HOCHMAN, JUDITH S · 1999 to 2010
$11.1M
NHLBI NIH HHS U01 HL062509
6 · The paper itself

Abstract

backgroundThe OAT study randomized 2,201 patients with a totally occluded infarct-related artery on days 3 to 28 (>24 hours) after myocardial infarction (MI) to percutaneous coronary intervention (PCI) or medical treatment (MED). There was no difference in the primary end point of death, reinfarction, or heart failure at 2.9 or 6-year mean follow-up. However, in patients randomized to PCI, there was a trend toward a higher rate of reinfarction.

methodsWe analyzed the characteristics and types of reinfarction according to the universal definition. Independent predictors of reinfarction were determined using Cox proportional hazard models with follow-up up to 9 years.

resultsThere were 169 reinfarctions: 9.4% PCI vs 8.0% MED, hazard ratio 1.31, 95% CI 0.97-1.77, P = .08. Spontaneous reinfarction (type 1) occurred with similar frequency in the groups: 4.9% PCI vs 6.7% MED, hazard ratio 0.78, 95% CI 0.53-1.15, P = .21. Rates of type 2 (secondary) and 3 (sudden death) MI were similar in both groups. There was an increase in type 4a reinfarctions (related to protocol or other PCI) (0.8% PCI vs 0.1% MED, P = .01) and type 4b reinfarctions (stent thrombosis) (2.7% PCI vs 0.6% MED, P < .001). Multivariate predictors of reinfarction were history of PCI before study entry (P = .001), diabetes (P = .005), and absence of new Q waves with the index infarction (P = .01).

conclusionsThere was a trend for reinfarctions to be more frequent with PCI. Opening an occluded infarct-related artery in stable patients with late post-MI may expose them to a risk of subsequent reinfarction related to reocclusion and stent thrombosis.

Indexed as

Angioplasty, Balloon, CoronaryCoronary AngiographyCoronary OcclusionFemaleFollow-Up StudiesHumansMaleMiddle AgedMyocardial InfarctionProportional Hazards ModelsRecurrence

Identifiers

PMID22520521
PMCPMC4238915
OpenAlexW2159642640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.